EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Navigating fluoroquinolone resistance in Gram-negative bacteria: a comprehensive evaluation

Linda Kherroubi, Joanna Bacon, Khondaker Miraz Rahman iD

JAC-Antimicrobial Resistance · 03.07.2024 · 6 (4)

DOI: 10.1093/jacamr/dlae127 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 14.08.2024. Verfasst von Linda Kherroubi und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Cancer and Pharmaceutical Science, King's College London, London SE1 9NH, UK. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MRC Impact Acceleration Award 2021 King’s College London.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the introduction of quinolone and fluoroquinolone antibiotics to treat bacterial infections in the 1960s, there has been a pronounced increase in the number of bacterial species that have developed resistance to fluoroquinolone treatment. In 2017, the World Health Organization established a priority list of the most critical Gram-negative resistant pathogens. These included Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Escherichia coli. In the last three decades, investigations into the mechanisms of fluoroquinolone resistance have revealed that mutations in the target enzymes of fluoroquinolones, DNA gyrase or topoisomerase IV, are the most prevalent mechanism conferring high levels of resistance. Alterations to porins and efflux pumps that facilitate fluoroquinolone permeation and extrusion across the bacterial cell membrane also contribute to the development of resistance. However, there is a growing observation of novel mutants with newer generations of fluoroquinolones, highlighting the need for novel treatments. Currently, steady progress has been made in the development of novel antimicrobial agents that target DNA gyrase or topoisomerase IV through different avenues than current fluoroquinolones to prevent target-mediated resistance. Therefore, an updated review of the current understanding of fluoroquinolone resistance within the literature is imperative to aid in future investigations.

Autor:innen und Institutionen

  • School of Cancer and Pharmaceutical Science, King's College London, London SE1 9NH, UK.
  • Discovery Group, Vaccine Development and Evaluation Centre, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK.

ORCID-Profile: Khondaker Miraz Rahman

Förderung

  • MRC Impact Acceleration Award 2021 King’s College London

Zitieren

APA

Kherroubi, L., Bacon, J., & Rahman, K. M. (2024). Navigating fluoroquinolone resistance in Gram-negative bacteria: a comprehensive evaluation. JAC-Antimicrobial Resistance, 6(4). https://doi.org/10.1093/jacamr/dlae127

Vancouver

Kherroubi L, Bacon J, Rahman KM. Navigating fluoroquinolone resistance in Gram-negative bacteria: a comprehensive evaluation. JAC-Antimicrobial Resistance. 2024;6(4). doi:10.1093/jacamr/dlae127

BibTeX
@article{Kherroubi2024,
  author = {Kherroubi, Linda and Bacon, Joanna and Rahman, Khondaker Miraz},
  title = {Navigating fluoroquinolone resistance in Gram-negative bacteria: a comprehensive evaluation},
  journal = {JAC-Antimicrobial Resistance},
  year = {2024},
  volume = {6},
  number = {4},
  doi = {10.1093/jacamr/dlae127}
}
Kostenlos starten →